Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
45 participants
INTERVENTIONAL
2003-02-28
2008-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microarray Application in Newborns With Multiple Congenital Anomalies
NCT06694896
Characterization of Cleft Lip and Palate Conditions in Guatemala
NCT04725370
Evaluation of Arch Dimensions of Children With Surgically Repaired Unilateral Cleft Lip and Palate
NCT03219021
TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000
NCT02203981
Quality of Life and Stigmatization in Children with Congenital Melanocytic Nevi Before and After Nevus Excision
NCT02280889
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
None: molecular genetics diagnosis procedure only
None: molecular genetics diagnosis procedure only
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parents agree to enrollment or patients, themselves, agree to enrollment when able to do so
* Healthcare insurance holders
* Display facial clefting
Grown patients over 18 years of age:
* Agree to enrollment
* Display facial clefting
* Healthcare insurance holders
Exclusion Criteria
* Patients without healthcare insurance
1 Month
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pascal TSCHILL, MD
Role: PRINCIPAL_INVESTIGATOR
Laboratoire de Génétique Molécules des Eucaryotes (LGME)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre d'Investigations Cliniques, Hôpital Civil, Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
Centre de Soins , d'Enseignement et de Recherche Dentaire (CESRD), Hôpital Civil, Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
Service de Chirurgie Infantile, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
Service de Consultation de la Face, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2602
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.